MiniMed FY26 net loss widens to $331 million; net sales climb 14.2% to $3.1 billion

MiniMed Group

MMED

0.00

Medtronic

MDT

0.00

MiniMed posted Q4 net sales of $837 million, up 15.6% year over year; net loss widened to $183 million.
Operating loss narrowed to $91 million; international net sales climbed 22.4% to $599 million while U.S. net sales rose 1.5% to $238 million.
FY26 net sales rose 14.2% to $3.1 billion; net loss attributable to the Company widened to $331 million.
CGM drove growth, rising 21.6% to $420 million in Q4; worldwide new pumps sold totaled about 42,000, up 7.4% quarter over quarter.
FY27 outlook calls for about 10% organic revenue growth, with adjusted EBITDA margin of about 16%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MiniMed Group Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606030646PR_NEWS_USPR_____CG74670) on June 03, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.